FindTrial
Sign In

A study to evaluate efficacy and safety of the test product on tanned skin.

A clinical study to evaluate the effectiveness of the test product on the tanned skin along with its safety on healthy adult female subjects. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071093
Enrollment
36
Registered
2024-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Night Cream: Approx. 1 to 1.5 gm of product will be applied every day at night before sleeping for 28 days Control Intervention1: NIL: NIL

Sponsors

Zydus Wellness Products Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects with fitzpatrick skin type IV and V. 2) Subjects with visible skin tan on face, at least 2 shade darker than a Sun protected upper volar arm. 3) Subjects with at least 2 dark spots / blemishes. 4) Subjects willing to provide written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Subjects with dark facial skin as determined by dermatologist. 2) Subjects who are receiving topical or systemic treatments for pigmentation within the last 30 days. 3) Subjects using other marketed skin lightening products during the study period or in the past 6 weeks. 4) Subjects using any other night cream during the study period.

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of test product on tanned skin, based on clinical, instrumental and subjective evaluationsTimepoint: Day 01, Day 03, Day 07, Day 14 and Day 28.—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Parth Joshi

Cliantha Research

ssethi@cliantha.com9825784942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026